The stock price of NGM Biopharmaceuticals has risen sharply following the announcement of a potential acquisition, which typically leads to positive investor sentiment in the short term as acquisitions can offer premiums over current stock prices. The formation of a special committee to review the offer further adds credibility to the potential deal, although the non-binding nature of the expression of interest means there is still uncertainty.